Home
>
National Drug Code (NDC)
>
LEUKOSEP - SOLX B ADDITIVE SOLUTION
LEUKOSEP - SOLX B ADDITIVE SOLUTION - 53157-301-01 - (SOLX B ADDITIVE SOLUTION)
Drug Information of LEUKOSEP - SOLX B ADDITIVE SOLUTION
| Product NDC: | 53157-301 |
| Proprietary Name: | LEUKOSEP - SOLX B ADDITIVE SOLUTION |
| Non Proprietary Name: | SOLX B ADDITIVE SOLUTION |
| Active Ingredient(s): | 1.78 g/30mL & nbsp; SOLX B ADDITIVE SOLUTION |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LEUKOSEP - SOLX B ADDITIVE SOLUTION
| Product NDC: | 53157-301 |
| Labeler Name: | Haemonetics Manufacturing Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA110059 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130515 |
Package Information of LEUKOSEP - SOLX B ADDITIVE SOLUTION
| Package NDC: | 53157-301-01 |
| Package Description: | 30 mL in 1 BAG (53157-301-01) |
NDC Information of LEUKOSEP - SOLX B ADDITIVE SOLUTION
| NDC Code | 53157-301-01 |
| Proprietary Name | LEUKOSEP - SOLX B ADDITIVE SOLUTION |
| Package Description | 30 mL in 1 BAG (53157-301-01) |
| Product NDC | 53157-301 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SOLX B ADDITIVE SOLUTION |
| Dosage Form Name | SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130515 |
| Marketing Category Name | NDA |
| Labeler Name | Haemonetics Manufacturing Inc |
| Substance Name | DEXTROSE |
| Strength Number | 1.78 |
| Strength Unit | g/30mL |
| Pharmaceutical Classes |
